Hoppenot Herve

Incyte Corp

Chairman / CEO, Director

Avg. Two Year Performance

28% Avg. Purchase Return 13% Compound

9% Avg. Sale Return 5% Compound

Holdings: 496.67K shares

Last Three Months: 25-Aug-24 -- 24-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions